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Introduction
Alkaline phosphatase [APase; orthophosphoric-monoester phosphohydrolase (alkaline optimum): E.C.3.1.3.11 is a member of the growing family of membrane-bound proteins anchored to the outer leaflet of the lipid bilayer via a glycosyl-phosphatidylinositol (GPI) moiety (11, 16, 17) . APase in human neutrophils, first identified in 1931, is a useful enzymatic marker for the stages of neutrophilic d&rentiation and maturation (1, 20) . Changes in neutrophil APase activity correlate with certain blood pathologies. Specifically, increased neutrophil APase activity has been observed in patients with polycythemia vera and osteomyelofibrosis, and decreased enzyme activity has been associated with chronic myelogenous leukemia, used for isolation and purification of neutrophil APase. SpecScalIy, neutrophils were treated with phosphatidylin&tol-specific phospholipase C to release GPI-anchored proteins from the cell surface. APase was putifred from supernatants of these preparations by electrophoresis in a non-denaturing gel system and subsequent electroelution. With this approach we rapidly purified neutrophil APase to homogeneity: this protein was then used for immunization. Immunoblotting, ELISA, and immunocytochemical localization were used to paroxsymal nocturnal hemoglobinuria, and acquired immune deficiency (5, 12, 15) .
APase is expressed in an intracellular pool (-80%) and to a lesser extent on the cell surface (-20%) in unstimulated neutrophils. Recently, our laboratory described the intracellular store for APase as a unique membrane-bound compartment distinct from the azurophil and specific granules (13) . Stimulation of neutrophils with the chemotactic peptide N-formyl-Met-Leu-Phe(fMLP) induces rapid translocation of essentially all of the APase (>go%) to sites in continuity with the cell surface (8J3). This exocytotic event is unusual in that the small APase-containing granules in resting cells fuse to form tubular arrays that become continuous with the extracellular space (13) . We now show that treatment of neutrophils with cytochalasin B before fMLP stimulation leads to an even more striking alteration in the distribution of APase than stimulation with fMLP alone.
We have taken advantage of the fact that cytochalasin BlfMLP treatment delivers APase to sites in continuity with the plasma membrane to develop a method for isolation and purification of APase from the surface of intact neutrophils. By employing a specific phos-pholipase that selectively cleaves glycosyl-phosphatidylinositol linkages, followed by electrophoresis in native polyacrylamide gels, we rapidly purified neutrophil APase to homogeneity. With this approach we were able to sidestep more complicated and timeconsuming detergent solubilization and n-butanol extraction methods that have been used by others to isolate GPI-anchored proteins (e.g., 18 ). The purified protein was then used for immunization. Immunoblotting, ELISA, and immunocytochemical localization were used to characterize polyclonal antibodies that detect neutrophil APase. A preliminary account of this work has appeared in abstract form (9) .
Materials and Methods

Reagents
The following chemicals were purchased from Sigma (St Louis, MO): bovine serum albumin, 5-bromo-4-chloro-3-indolyl phosphate (BCIP), citric acid, cytochalasin B, dextran (MW *485,000), EDTA, Ficoll-Histopaque 1083, Hanks' balanced salt solution (Hanks'), levamisole, MW markers (SDS-7B) N-formyl-Met-Leu-Phe, nitroblue tetrazolium (NBT), pepstatin A, phenylmethylsulfonyl fluoride, p-nitrophenyl phosphate, poly-Llysine, saponin, sodium tetrathionate, 3,3',5,S-teuamethylbcnzidine, and Triton X-100. Phosphatidylinositol-specific phospholipase C was obtained from Boehringer-Mannheim (Indianapolis, IN). Glutaraldehyde (25% aqueous), sodium cacodylate, and MOWIOL were from Polysciences (Warrington, PA). Immobilon PVDF membranes were from Millipore (Bedford,MA). 1.4-Phenylenediamine was from Aldrich (Milwaukee, WI). Centricon-10 tubes were from Amicon (Beverly, MA). The BCA Protein Assay kit and the SDS-PAGE silver staining kit were supplied by Pierce (Rockford, IL) and Bio Rad (Richmond, CA), respectively. Epon 812 was supplied by Balzers Union (Hudson, NH). Rabbit anti-human lactoferrin IgG, secondary antibodies [goat anti-rabbit IgG peroxidase-labeled and fluorescein isothiocyanate (F1TC)-conjugated goat anti-rabbit IgG F(ab)2] were purchased from Organon Teknika-Cappel (Durham, NC). Freund's adjuvant was supplied by Difco (Detroit, MI). The anesthetics ketamine and xylazine were obtained from Fort Dodge Labs (Fort Dodge, IA) and Mobay (Shawnee, KS), respectively. All other reagents were of the highest grade available.
Isolation of Cells
Human neutrophils were isolated and purified from whole blood obtained from healthy adult men (3). Coagulation was prevented by acid citrate-6% dextran (MW -485,000) and leukocytes were isolated by sedimentation (1 x g) at 4°C for 30-40 min. The leukocyte-enriched upper phase was layered onto Ficoll-Histopaque 1083 and centrifuged at 150 x g for 30 min at 4'C. Erythrocytes in the resulting pellet were lysed for 15-20 sec with ice-cold dH2O and then brought to isotonicity by addition of HBSA [Hanks' without Ca++ and Mg" supplemented with 0.1% bovine serum albumin (BSA)]. Neutrophils accounted for 98% of the cells, as determined by differential staining. The cells were washed an additional time in HBSA and stored on ice before use. Cell viability was always 290% as determined by trypan blue exclusion. Informed consent was obtained from the volunteers who provided blood after an explanation of the nature and consequences of the studies. In addition, all investigations involving human material were performed with the approval of the Human Investigations Committee, The Ohio State University, in accord with an assurance filed with and approved by the Department of Health and Human Services.
Ceil Stimulation
The neutrophil preparation was washed once in cold PBS (-/-/-) (137 mM NaCI, 2.7 mM KCI, 6.45 mM NazHP04, 1.47 mM KH2P04, pH 7.35) to remove the BSA and re-suspended in 10 ml cold PBS (+ + +) (137 mM NaCI, 2.7 mM KCI, 6.45 mM Na2HP04, 1.47 mM KH2P04, 0.9 mM CaC12, 0.5 mM MgC12, 7.5 mM glucose, pH 7.35) to yield a working cell concentration range of 10-20 x lo6 cellslml. 'Men from ice the cells were then pretreated with cytochalasin B (cyto B) (5 pglml) for 6 min at 37'C, followed by addition of the chemotactic peptide fMLP (lo-' M) (2, 24) . Stimulation by fMLP was carried out at 37'C for 5 min. This resulted in almost complete translocation of APase to sites continuous with the phmalemma (8,13, confirming data not shown); cytochalasin B treatment minimized subsequent internalization of the plasmalemma. Thus, APase at the cell surface was maximally susceptible to phosphatidylinositol-specific phospholipase C (PI-PLC)-mediated release.
Cytochemistry
The ultrastructural localization of APase was carried out by a cerium-based cytochemical technique described previously (13) . In brief, stimulated or unstimulated cells were fixed with 2% glutaraldehyde in 0.1 M cacodylate buffer containing 5% sucrose for 20 min. The cells, in fixative, were layered onto poly-L-lysine-coated glass coverslips. All subsequent incubation steps were done with cells cross-linked to and immobilized on the coverslips (19) . The standard cytochemical medium contained low amounts of detergent for cell permeabilization (0.006% Triton X-100 and 0.004% saponin). In some cases the permeabilization agents were omitted. After the cytochemical incubations the cells were dehydrated and subsequently embedded in Epon 812. Thick sections (-0.75 pm thick) were cut, collected on grids, and coated with a thin layer of evaporated carbon. The sections were examined with a Philips CM-12 electron microscope operated at 120 kV.
Isolation and Purij5cation of Alkaline Phosphatase
Before incubation with PI-PLC the cells were washed twice in excess PBSK (2.7 mM NaCI, 137 mM KCI, 6.45 mM Na2HP0.4, 1.47 mM KHzP04, pH 7.3) to remove the high NaCl concentration shown to inhibit PI-PLC activity (23) . Stimulated cells (10-20 x lo6 cellslml) were re-suspended in 10 ml of PBSK and subsequently incubated with PI-PLC (500 mUlml) for 45 min at 37°C. After PI-PLC treatment the cells were pelleted; the supernatant was saved and the cell pellet was discarded. Proteins in the supernatant were subsequently concentrated by centrifugal ultrafiltration in Amicon Centricon-10 tubes (7). The concentrated protein sample was then mixed 1:1 with native sample buffer containing 0.5 M Tris-HC1, 20% glycerol, pH 6.8, and electrophoresed on 12% non-denaturing polyacrylamide gels for 3.5 hr at 100 V with a Bio Rad minigel apparatus. After electrophoresis the gels were washed twice in cold TBS-Mg (100 mM Xis, 100 mM NaCI, 5 mM MgC12, pH 9.5) buffer to equilibrate the pH of the gels. The gels were incubated at 37'C in the same buffer system containing the substrates BCIP (445 pM) and NBT (202 pM) for detection of APase activity. A band demonstrating APase activity was visualized in the gels within 5-10 min. The gels were subsequently stained with the Bio Rad silver staining kit to detect the presence of other proteins. The enzymatically stained band was then cut from the gels and the protein electroeluted from minced gel fragments at 60 V for 5 hr with a Bio Rad 422 Electro-Eluter (6). The resultant sample was concentrated by centrifugal ultrafiltration in Centricon-10 tubes. The protein concentration was subsequently determined by the BCA protein assay before analysis of the protein in a one-dimensional denaturing gel system (14) Biochemistry To ascertain the relative amount of APase released from the neutrophil plasma membrane on PI-PLC treatment, aliquots were taken from untreated and cyto BlfMLPIPI-PLC-treated cell suspensions and assayed for APase activ-ity. In each experiment the cells were centrifuged and the resultant pellet Antibody Analvjjj was stored at -70'C. The pellets were re-suspended in 200 p1 PBSK and homogenized with an OMNI 1000 handheld electric homogenizer (OMNI International: Waterbury, CT) for 20 sec at 20.000 RPM. Aliquots of the homogenate were then assayed for detection of APase activity withp-nitrophenyl phosphate as substrate. The assays were initiated with the addition of substrate (4 mM) and carried out in TBS-Mg buffer at 37°C. The activity was measured spectrophotometrically by monitoring the accumulation of product, p-nitrophenol, at 410 nm. In addition, the protein concentration of the cell homogenate samples was determined by the BCA protein assay. The APase activity of untreated and PI-PLC treated samples was calculated as pmol product (p-nitrophenol) formed/ pg protcin/min and compared relative to each other. . ,
Immunization
Immunoblotting. Western blots of human neutrophil whole-cell lysates and purified APase were carried out. Proteins were resolved on 12% SDS-PAGE and elecvoblotted onto Millipore Immobilon PVDF membranes. The membranes were blocked with 4% BSA and probed with sera (1:2000) from the neutrophil APase-immunized rabbits. Detection of antibodies was demonstrated with a peroxidase-conjugated goat anti-rabbit IgG secondary antibody.
ELISA. Rabbit sera were also analyzed by ELISA. Briefly. purified neutrophil APase was bound to 96-well microtiter plates from Corning (Corning, NY) at a fixed concentration of 300 nglwcll. After nonspecific blocking with 1% BSA the wells were probed with serially titrated rabbit sera. Peroxidase-conjugated goat anti-rabbit IgG was then used to detect antibodies to APax with the enzymatic substrate 3.~,5,5'-tetramethylbenzidine. After visualization of the reaction product the sample wells were acidified by addition ofH2S04 and optically scanned at 405 nm with a Bio Rad 3550 Microplate Reader.
Immunocytochemistry. The distribution of APase in neutrophils was determined by indirect immunofluorescence. Unstimulated cells in suspension were fixed in 3.5% paraformaldehydc/O.l% glutaraldehyde containing the protease inhibitors sodium tetrathionate (4 mM), pepstatin A (30 pM), phenylmethylsulfonyl fluoride (4 mM). and EDTA (1 mM) (22) and then sported down onto and immobilized to 0.2% poly-~-lysine-coated glass coverslips for 45 min. To detect the APase-positive intracellular compartment, permeabilized cells (0.3% saponin10.05% Triton X-100) were incubated with the rabbit anti-neutrophil APasc, followcd by goat anti-rabbit 
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sistcd of cells incubated with either rabbit pre-immune sera or no primary antibody. The samples were mounted in MOWIOL containing 1 mglml 1.4-phenylenediamine (to minimize photobleaching) and observed with a Bio Rad MRC-GOO scanning laser confocal microscope.
Results
Cy tochemistry
Enzyme cytochemical analysis at the ultrastructural level was used to determine the distribution of APase activity in unstimulated and cyto BlfhfLP-stimulated human neutrophils. Unstiulated cells have an intracellular compartment that stains for this activity. Localization of this activity required cell permeabilization ( Figures 1A and  1B ) and showed that APase activity is primarily intracellular in unstimulated cells. Treatment of cells with cyto B and fMLP induced a dramatic alteration in cell morphology and in the distribution of APase activity ( Figures 1C and ID) . The bulk of the cytochemically demonstrable activity in cyto BlfhfLP-stimulated cells was in continuity with the extracellular space and did not require cell permeabilization to visualize the APase-catalyzed reaction product. The cytochemical reaction product was found predominantly in tubular invaginations of the cell surface and was thus in continuity with the plasma membrane.
Purz3cation of Neutrophil APase
Neutrophils pre-treated with cyto B followed by fMLP stimulation maximally expressed the GPI-anchored APase at sites continuous with the cell surface (>go%), leaving the enzyme susceptible to liberation by a GPI-targeted phospholipase (specifically PI-PLC). The supernatants from the PI-PLC-treated cells were collected, concentrated, and run out on 12% non-denaturing polyacrylamide gels. Native APase was identified by staining the gels for enzyme activity by conventional NBTIBCIP methodologies. A single band demonstrating APase was observed within 5-10 min after addition of the substrates. The native gels were then silver-stained, revealing the presence of several additional proteins in other regions of the gel (Figure 2) . Native gels incubated with levamisole, an APase inhibitor (e.g., 13), during the enzyme-catalyzed staining showed very little reaction product, thus substantiating the specificity of the reaction (data not shown). The band stained for APase activity was electroeluted. concentrated, and run out on 12% SDS-PAGE gels. Silver staining of this SDS-PAGE gel revealed a single band with a relative MW of -70 KD (Figure 2) .
Biochemistry of PI-PLC-mediated Hydrolysis
To ascertain the dficiency of APase release from the neutrophil plasma membrane by PI-PLC, untreated and cyto BlfMLPIPI-PLCtreated cell homogenates were assayed biochemically for total cellassociated APase activity. Results were recorded as pmol of product/% proteinlmin at 37°C. The values for five preparations of untreated neutrophils were averaged and defined as 100%. The effect of PI-PLC treatment in five additional cell preparations was determined and then compared with the untreated samples. Comparing the total cell-associated APase activity that remained in the cell homogenates from both untreated and PI-PLC-treated cells demonstrated that the lipase treatment caused release of 75 % (SD 8.8) of the APase (Figure 3 ).
. ** Untreated PI -P I,C t re at ed 
Antibodies to Neutrophil APuse
Immunoblotting. Western blots of human neutrophil wholecell lysates and purified APase were probed with sera from the neutrophil APase-immunized rabbits. Single bands in the whole-cell lysate and the purified antigen samples in the same MW range were demonstrated (Figure 4) . Blots probed with pre-immune rabbit sera showed no anti-APase recognition (data not shown).
ELISA. Purified neutrophil APase immobilized on microtiter plates at a constant concentration of 300 nglwell were probed with serially titrated rabbit sera from immunized and pre-immune rabbits. Antibodies to APase were identified with a peroxidase-labeled anti-rabbit IgG and tetramethylbenzidine detection system. ELISA analysis of the rabbit sera demonstrated anti-APase recognition directed against the purified antigen up to a dilution of 1:10,000 (data not shown).
Immunocytochemistry. Rabbit sera were also analyzed for their ability to recognize neutrophil APase in situ by indirect immunocytochemistry. Fixed and permeabilized neutrophils immobilized on glass coverslips were probed with rabbit polyclonal antineutrophil APase sera. Antibody-APase recognition was detected by subsequent incubation of the cells with an FIX-labeled F(ab)z secondary antibody and examination with a scanning laser confocal microscope. The unstimulated cells incubated with the rabbit polyclonal anti-neutrophil APase showed a distribution pattern similar to that of the permeabilized cells incubated for enzyme-catalyzed cytochemical demonstration of intracellular APase (Figure l) abundance ( Figures 5A and 5B) . Figures 5C and 5D showed unstimulated cells probed with rabbit anti-human lactoferrin. a protein marker for the specific granule. and detected by the same secondary IgG. In this case the labeling pattern showed a granule population that was larger and more abundant. Control samples probed with either rabbit pre-immune serum or no primary antibody did not exhibit fluorochrome labeling (data not shown).
Discussion
To further characterize the novel intracellular compartment we recently described in human neutrophils, GPI-anchored APase, a protein marker for this compartment, was'purified from intact cells and rabbit polyclonal antibodies were generated. We described here a procedure for up-regulation of this protein to the cell surface and rapid purification of APase based on its sensitivity to hydrolysis by PI-PLC and the ability to detect directly the activity of this enzyme in a non-denaturing PAGE system. In unstimulated cells APase is predominately intracellular, but on stimulation of neutrophils with the chemotactic peptide fh4LP the enzyme can be up-regulated to sites in continuity with the plasma membrane (8.13). Neutrophils possess cell surface receptors for this peptide (24) that on ligand-receptor binding trigger an elaborate signal transduction cascade, eliciting a variety of physiological responses including supetoldde generation (e.g.. 4). Pre-treatment of cells with the actintargeting drug cyto B before fMLP stimulation minimizes subsequent membrane internalization (2) and leads to maximal expression of APase to sites in continuity with the cell surface, leaving the protein susceptible to liberation from the bilayer by a lipase that specifically hydrolyzes phosphatidylinositol moieties. The ability to up-regulate APase to the cell surface and subsequently cleave it off with PI-PLC is of great advantage in purification of this GPI-anchored protein. Time-consuming and complicated cell fractionation and organelle isolation procedures are not required, reaffirming the utility of PI-PLC for isolating GPIanchored proteins (10.17) . Visualization of the enzymatic activity of APase in a non-denaturing PAGE system further hastened the purification of this protein to homogeneity. Subsequent immunization of rabbits with the purified protein resulted in positive polyclonal antibodies to the GPI protein. With this probe for APase, we will perform co-localization experiments to determine whether other neutrophil GPI-linked proteins [e.g., complement decay accelerating factor (lo), the R receptor for IgG, FcyR IIIB (CD16) (21)] are present in this compartment. This will enable us to test the hypothesis previously raised (U), i.e., that this compartment is the intracellular store of GPI-linked proteins that can be upregulated to the cell surface in a stimulus-dependent manner in human neutrophils.
